Great West Life Assurance CO Travere Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,902 shares of TVTX stock, worth $125,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,902
Previous 6,902
-0.0%
Holding current value
$125,478
Previous $57,000
70.18%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TVTX
# of Institutions
193Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$139 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$139 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$125 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$85.2 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$78.9 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.17B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...